Olin Corporation manufactures and distributes chemical products in the United States, Europe, and internationally.
$17.31-4.15%
报价 2026-11-06
市值
$1.97B
EV
$5.16B
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -42.6%
$14.71$30.14
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07仅 EPS 线✗ 收入线✓ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 0.33 → 0.29（0.9x） | 59.5 |
| FY+32028-12 | 1.1x | 0.33 → 1.21（3.7x） | 14.3 |
毛利率 7% · TTM 收入 $6738M · 基数 EPS 0.33（调整后）
分歧大低毛利利润率驱动一次性亏损已剔除
电话会信号
辅助标签Q3 20262026-10-30
扩产
指引 无
信心 4
分析师 3
“We expect to close the Huntsman merger in Q1 2027 and deliver more than $400 million of cost synergies.”
原文引用（1）
- 扩产：Our interim production capacity is expected to scale by a factor of 10 by the completion of the project as the new manufacturing facility is built out.
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| OLNOlin Corporation | $1.97B | -4.2% | +2.1% | 9.9% | – | 11.8x | 8.9x | |
| DDDuPont de Nemours, Inc. | $19.79B | +1.1% | +4.7% | 35.1% | 279.3x | 14.1x | 15.4x | |
| RPMRPM International Inc. | $13.18B | -2.0% | +5.3% | 41.2% | 18.4x | 13.4x | 22.5x | |
| AVTRAvantor, Inc. | $10.48B | +2.2% | +2.2% | 31.5% | 30.9x | 15.1x | 23.9x | |
| WLKWestlake Corporation | $8.11B | -4.2% | +2.9% | 12.8% | – | 17.6x | 676.2x | |
| AXTAAxalta Coating Systems Ltd. | $7.8B | +0.3% | +1.2% | 34.5% | 22.1x | 8.3x | 15.6x | |
| ESIElement Solutions Inc | $7.64B | +1.9% | +50.7% | 34.4% | 41.9x | 22.5x | 48.8x | 高增长 |
| EMNEastman Chemical Company | $7.36B | -2.0% | +4.4% | 21.1% | 16.4x | 9.5x | 17.4x | |
| BCPCBalchem Corporation | $5.56B | -2.9% | +9.6% | 36.5% | 33.9x | 20.4x | 27.2x | |
| 同行中位数 | – | – | +4.5% | 34.5% | 30.9x | 14.6x | 23.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.75B | $1.74B | $1.58B | $1.67B | $1.71B | $1.76B | $1.64B | $1.67B |
| Gross Margin | 9.9% | 9.8% | 4.8% | 1.9% | 10.7% | 7.9% | 9% | 9.4% |
| Operating Margin | 3.4% | 2.7% | -4.4% | -3.8% | 0% | 2% | 2.7% | 2.8% |
| Net Income | $14.4M | $-13.3M | $-83M | $-85.7M | $43M | $-1.3M | $1.4M | $10.7M |
| Diluted EPS | 0.13 | -0.12 | -0.73 | -0.75 | 0.37 | -0.01 | 0.01 | 0.09 |
| Operating Cash Flow | $110.4M | $7.9M | $-48.6M | $321.2M | $26.7M | $212.3M | $-86M | $141.7M |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。